A randomized trial of aspirin to prevent colorectal adenomas

Authors :: Baron, John A.
Cole, Bernard F.
Sandler, Robert S.
Haile, Robert W.
Ahnen, Dennis
Bresalier, Robert
McKeown-Eyssen, Gail
Summers, Robert W.
Rothstein, Richard
Burke, Carol A.
Snover, Dale C.
Church, Timothy R.
Allen, John I.
Beach, Michael
Beck, Gerald J.
Bond, John H.
Byers, Tim
Greenberg, E. Robert
Mandel, Jack S.
Marcon, Norman
Mott, Leila A.
Pearson, Loretta
Saibil, Fred
Stolk, Rosalind U. van
Source :: The New England Journal of Medicine. March 6, 2003, Vol. 348 Issue 10, p891, 9 p.
Publication Year :: 2003
Abstract: Low-doses of aspirin may prevent colorectal cancer from getting worse, according to a study of 1,121 patients who had recently been diagnosed with colorectal tumors. The progression of the cancer was slower in patients who took 81 milligrams of aspirin, compared to the patients who took 325 milligrams of aspirin or a placebo.

Tools